NDC 42292-028-01 - Sulfamethoxazole and Trimethoprim
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 42292-028
- Requested NDC
- 42292-028-01
- Package NDCs from labels
- 42292-028-01, 42292-028-08
- Manufacturer
- Mylan Institutional Inc.
- Effective date
- 2019-11-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Sulfamethoxazole and Trimethoprim Tablets, USP | Mylan Institutional Inc. | 2019-11-07 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 42292-028-01 | EA - Each | 42292-028 | 82d7d58a-f7df-454e-8242-7401b0345200 | 1 | 2016-12-07 |
| 42292-028-08 | EA - Each | 42292-028 | 82c38478-2a7a-47f8-9fc7-c8b627d74c22 | 1 | 2016-12-07 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Stool Softener | DOCUSATE SODIUM | Strategic Sourcing Services LLC | 24e29f00-f1cf-4e92-bd67-3f6f820af783 | 2026-01-07 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative Extra Strength | DOCUSATE SODIUM | P & L Development, LLC | 33000a06-e030-433a-8f9c-7ae5c08037fa | 2026-01-06 | Warnings | F05Q2T2JA0 |
| Stool Softener Regular Strength | DOCUSATE SODIUM | Sam's West, Inc | 1eca5910-b0bf-4e07-8211-36dba52b3de7 | 2026-01-06 | Warnings | F05Q2T2JA0 |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | NuCare Pharmaceuticals,Inc. | 8c3e4738-0e0a-a854-e053-2995a90a7d71 | 2026-01-05 | Warnings, Adverse reactions | ANDA090624 198335 AN164J8Y0X JE42381TNV |
| SULFATRIM | SULFAMETHOXAZOLE AND TRIMETHOPRIM | A-S Medication Solutions | 80f7f00b-add4-4d6b-9e9c-bea29768c239 | 2026-01-05 | Warnings, Adverse reactions | AN164J8Y0X JE42381TNV |
| Senna S | DOCUSATE SODIUM, SENNOSIDES | Safeway, Inc. | acb40b29-5fd5-4864-b6bf-4102e47a1683 | 2026-01-05 | Warnings | F05Q2T2JA0 |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | Northwind Health Company, LLC | f2b8e9d9-1274-22ca-e053-2a95a90a6f1a | 2026-01-01 | Warnings, Adverse reactions | 198335 AN164J8Y0X JE42381TNV |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | Northwind Health Company, LLC | f7f97520-d063-ec87-e053-6294a90aae0c | 2026-01-01 | Warnings, Adverse reactions | ANDA090624 198335 AN164J8Y0X JE42381TNV |
| Senna-S | SENNOSIDES AND DOCUSATE SODIUM | RMT HEALTH LLC | 4742182e-fdf9-44fe-e063-6394a90adfcc | 2025-12-31 | Warnings | F05Q2T2JA0 |
| Docusate Sodium Liquid | DOCUSATE SODIUM | LLORENS PHARMACEUTICALS INTERNATIONAL DIVISION | 2d8bdd3e-f6e6-43f5-b3b0-e5a882cae41c | 2025-12-31 | Warnings | F05Q2T2JA0 |
| Senna-S | DOCUSATE SODIUM 50MG AND SENNOSIDES 8.6MG | Walgreens | 36cc3a5b-1891-d39e-e063-6294a90a93b4 | 2025-12-31 | Warnings | F05Q2T2JA0 |
| Docusate Sodium Liquid | DOCUSATE SODIUM | RUGBY LABORATORIES | e21d19d8-6c2d-4474-a663-dfe7e91ac320 | 2025-12-30 | Warnings | F05Q2T2JA0 |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | Northwind Health Company, LLC | 471c5995-a4df-fbe3-e063-6394a90aa50e | 2025-12-29 | Warnings, Adverse reactions | ANDA090624 198335 AN164J8Y0X JE42381TNV |
| Senna-S | SENNA-S | Pioneer Life Sciences, LLC | ab46a3ca-6c7a-a81e-e053-2995a90a199f | 2025-12-29 | Warnings | F05Q2T2JA0 |
| Medicated Cornstarch Baby Powder | ACTIVE CORN STARCH | Davion, Inc. | e39032d1-c8cd-4a41-af10-126970b8ad38 | 2025-12-29 | Warnings | O8232NY3SJ |
| Senna-S | SENNOSIDES 8.6MG AND DOCUSATE SODIUM 50MG | Pharbest Pharmaceuticals, Inc. | 2b5152b2-d354-409f-a19f-b470f4181b3f | 2025-12-24 | Warnings | F05Q2T2JA0 |
| Senna Plus | DOCUSATE SODIUM 50 MG AND SENNOSIDES 8.6 MG | CARDINAL HEALTH, 110 DBA LEADER | 4d4101ca-7d78-4712-9b3d-f395f2646c6b | 2025-12-23 | Warnings | F05Q2T2JA0 |
| Senna-S | SENNOSIDES 8.6 MG AND DOCUSATE SODIUM 50 MG | NUVICARE LLC | 9e999e4a-2f72-4a2b-a41b-bdd68bf5a350 | 2025-12-19 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative | DOCUSATE SODIUM | P & L Development, LLC | cb0765cb-f48e-4daa-97b8-2897a2d95587 | 2025-12-19 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative | DOCUSATE SODIUM | Strategic Sourcing Services LLC | ba51cca1-b70b-476e-80e6-20cd52292e65 | 2025-12-17 | Warnings | F05Q2T2JA0 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.